Pharmacy World & Science

, Volume 30, Issue 2, pp 147–153 | Cite as

A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies

  • Shalom I. BenrimojEmail author
  • Joel B. Werner
  • Catherine Raffaele
  • Alison S. Roberts


There is a growing trend, globally, for consumers to self-medicate with non-prescription medications for common ailments. Pharmacists and pharmacy assistants are thought to be in a unique position to support consumers’ purchases of these medicines through the application of knowledge and skills, in an environment in which safety and quality remains paramount. Standards of practice have been developed by the profession to address the provision of these medicines, using a consumer-focused and risk management approach.

The application of these standards has been monitored since 2002, by the Quality Care Pharmacy Support Centre (QCPSC), created as a joint venture between the University and the Pharmacy Guild of Australia. The establishment of the QCPSC has allowed the development of a system to monitor and improve the application of standards for the provision of non-prescription medicines to consumers in community pharmacies in Australia. This system is unique in two aspects. The first is the use of pseudo-patient methodology, also called “mystery shoppers”, “pseudo-customers” and “simulated patients”, for the purpose of both assessment and quality improvement. The second unique aspect is the capturing of data based on assessments of behaviour in practice environments.

To date, the centre has conducted 14,738 standards maintenance assessment (SMA) visits, involving over 4,200 pharmacies across all states and territories in Australia. The data generated by such a system create a feedback mechanism for policy decision-making in the area of Quality Use of Medicines (QUM) for non-prescription medicines, which is of critical importance to the health and safety of consumers.


Australia Community pharmacy Non-prescription medicines OTC Pseudo-patient Quality assurance 



The authors would like to acknowledge the Pharmacy Guild of Australia for providing funding to the Quality Care Pharmacy Support Centre.


  1. 1.
    Australian Government Department of Health and Ageing. The national strategy for quality use of medicines. Commonwealth of Australia, Canberra, 2002.$FILE/natstrateng.pdf. Accessed Oct 2004.
  2. 2.
    Government of New South Wales. Poisons and therapeutic goods act 1966, 2004.
  3. 3.
    National Coordinating Committee on Therapeutic Goods (NCCTG). A report to the Australian health ministers’ conference on the results of the research into a cost-benefit analysis and risk assessment of pharmacist only (S3) and pharmacy medicines (S2) and risk-based evaluation of the standards. Canberra: Australian Government Department of Health and Ageing; 2005.Google Scholar
  4. 4.
    Australian Self-Medication Industry. Self care in Australia: the foundation for a healthy nation. 2005.
  5. 5.
    Therapeutic Goods Administration. NDPSC Record of reasons. 2003.
  6. 6.
    World Self-Medication Industry. Legal status of selected ingredients worldwide. 2004.
  7. 7.
    Benrimoj SI. A cost-benefit analysis of pharmacist only (S3) and pharmacy medicines (S2) and risk based evaluation of the standards [Final report]. University of Sydney. 2005.Google Scholar
  8. 8.
    Galbally R. National competition review of drugs, poisons and controlled substances legislation (final report), in council of Australian governments review. 2001.Google Scholar
  9. 9.
    Benrimoj SI, Gilbert A, Qunitrell N, de Almeida Neto AC. Non-prescription medicines: a process for standards development and testing in community pharmacy. Pharm World Sci 2007;29:386–94.PubMedCrossRefGoogle Scholar
  10. 10.
    Benrimoj SI, Wilson F. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy (Revised, November 2005), In: Professional Practice Standards (Version 3), editor. Canberra: The Pharmaceutical Society of Australia; 2006.Google Scholar
  11. 11.
    The Pharmacy Guild of Australia. Quality care pharmacy program. 1998.Google Scholar
  12. 12.
    The Commonwealth Department of Health and Ageing. Third community pharmacy agreement between the commonwealth of Australia and the pharmacy guild of Australia. 2000.Google Scholar
  13. 13.
    Pharmaceutical Society of Australia. Professional practice standards (Version 3). Curtin: Pharmaceutical Society of Australia; 2006.Google Scholar
  14. 14.
    The Pharmacy Guild of Australia, QCPP major program changes. 2003.
  15. 15.
    The Pharmacy Guild of Australia. 2006. Accessed January 2006.
  16. 16.
    The Commonwealth Department of Health and Ageing. Fourth community pharmacy agreement between the commonwealth of Australia and the pharmacy guild of Australia. 2005.Google Scholar
  17. 17.
    de Almeida Neto AC, Benrimoj SI, Kavanagh DJ, Boakes RA. Novel educational training program for community pharmacists. Am J Pharm Educ 2000;64:302–7.Google Scholar
  18. 18.
    Watson MC, Norris P, Granas A. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract 2006;14(2):83–93.CrossRefGoogle Scholar
  19. 19.
    Benrimoj SI, Werner JB, Raffaele C, Costa FA, Roberts AS. Monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies: results of a national program. Qual Saf Health Care. 2007 [in press].Google Scholar
  20. 20.
    Benrimoj SI, Raffaele C, Werner JB. Improving the quality of service delivered by Australian community pharmacies in the management of non-prescription medicines: a pseudo-patron study [Abstract]. In: International social pharmacy workshop, Oxford; 2006.Google Scholar
  21. 21.
    Watson MC, Skelton JR, Bond CM, Croft P, Wiskin CM, Grimshaw JM et al. Simulated patients in the community pharmacy setting. Pharm World Sci 2004;26:32–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Watson MC, Bond CM, Grimshaw JM, Johnston M. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care 2006;15:53–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther 2005;30(1):45–57.PubMedCrossRefGoogle Scholar
  24. 24.
    Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CS, Airaksinen MS. Progress in patient counselling practices in finnish community pharmacies. Int J Pharm Pract 2005;13(2):149–56.CrossRefGoogle Scholar
  25. 25.
    Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants’ practice in dealing with direct requests for non-prescription analgesics. Int J Pharm Pract 2002;10(1):23–9.Google Scholar
  26. 26.
    Watson MC, Bond CM, Grimshaw JM, Mollison J, Ludbrook A, Walker AE. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract 2002;19:529–36.PubMedCrossRefGoogle Scholar
  27. 27.
    Australian Health Ministers’ Advisory Council. Guidelines for national drugs and poisons schedule committee. 1997.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Shalom I. Benrimoj
    • 1
    • 2
    Email author
  • Joel B. Werner
    • 1
  • Catherine Raffaele
    • 1
  • Alison S. Roberts
    • 1
  1. 1.Quality Care Pharmacy Support Centre, Pharmacy Guild of AustraliaUniversity of SydneySydneyAustralia
  2. 2.Strategy Implementation and Sustainability Planning OfficeA14 (L4.36) University of SydneySydneyAustralia

Personalised recommendations